CoreAge Rx vs Belle Health
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Belle Health head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
Belle Health
FDA warning letter, February 2026 — issued to Belle Health LLC dba Belle. See the FDA's warning letter database.
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 79 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Belle Health a bad call — it's best for readers comparing longer supply plans who want named pharmacy partners and included nutrition support. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Belle Health |
|---|---|---|
| Brief Score | 94/100 (A) | 79/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | $199 for a 1-month supply; $93/mo with a 12-month supply (payment schedule unconfirmed) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | $249 for a 1-month supply; $179/mo with a 12-month supply (payment schedule unconfirmed) |
| Coverage | US only; restrictions by state, confirmed at intake | All 50 states and D.C. advertised; treatment and pharmacy availability vary |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Injection only | Injection only |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Belle Health: One-month supplies are listed at $199 semaglutide or $249 tirzepatide. Lower monthly equivalents require longer supplies; confirm payment timing and refund limits.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.